The South African Health Products Regulatory Authority (SAHPRA) has announced a sweet-tasting, heat-stable “4-in-1” fixed dose of four anti-retrovirus (ARV) treatments consisting of abacavir, lamivudine, ropinavir,...
This article first appeared conversation.. Women make up More than half Young women aged 10 to 24 years who live with HIV around the world are...
Review by Emily Henderson, Bachelor of ScienceOctober 30, 2020 Current HIV antiretroviral treatments are very effective, but data show that people living with HIV experience accelerated...
A global study on injectable HIV preexposure prophylaxis (PrEP) drugs was discontinued early after researchers found the drug to be very effective. Long-acting antiretroviral drugs given...
Elizabeth MelabOther works by this author A global study on injectable HIV preexposure prophylaxis (PrEP) drugs was discontinued early after researchers found the drug to be...
Recent Comments